Tzippy Shochat - Concepedia

Author

Tzippy Shochat

Rabin Medical Center ORCID

Also Known As

Shochat, T., T Shochat, T. Shochat, T., Shochat, Tzipora Shochat, Tzippora Shochat, Tzippy Shochat

260

Publications

3.4K

Citations

H-Index

104

Concepts

All Affiliations

Rabin Medical Center Tel Aviv University Sheba Medical Center Rambam Health Care Campus Soroka Medical Center

About

Tzippy Shochat is an author at Rabin Medical Center specializing in medicine, public health, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	26	1.2K
2	Public Health	8	8	256
3	Health Sciences	3	3	154
4	Social Sciences	1	1	13
5	Behavioral Sciences	1	1	40

Tzippy Shochat

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors Elizabeth Dudnik, Nir Peled, Hovav Nechushtan, Journal of Thoracic Oncology Tumor Mutational BurdenDeath Ligand 1MedicineImmunologyCancer Genomics	2018	219
Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer Raz Mutai, Tamar Barkan, Assaf Moore, The Breast	2021	132
Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data Elizabeth Dudnik, Mor Moskovitz, Sameh Daher, Lung Cancer Real-life DataMedicineCancer ManagementImmune Checkpoint InhibitorCancer Treatment	2017	101
ALK-Rearranged Non–Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism Alona Zer, Mor Moskovitz, David Hwang, Clinical Lung Cancer	2016	98
Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi) Elizabeth Dudnik, Elias Bshara, Ahuva Grubstein, Lung Cancer MedicineImmunologyPathologyBronchial NeoplasmImmune Checkpoint Inhibitor	2018	74
Gender differences in homocysteine concentrations, a population-based cross-sectional study E Cohen, Ili Margalit, Tzippy Shochat, Nutrition Metabolism and Cardiovascular Diseases Gender DifferencesCohort StudyMenopauseClinical ChemistrySex Difference	2018	69
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data Elizabeth Dudnik, Mor Moskovitz, Yakir Rottenberg, OncoImmunology	2021	68
Markers of Chronic Inflammation in Overweight and Obese Individuals and the Role of Gender: A Cross-Sectional Study of a Large Cohort Eytan Cohen, Ili Margalit, Tzippy Shochat, Journal of Inflammation Research	2021	68
Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low? Gloria Tsvetov, Oren Amitai, Tzippy Shochat, Osteoporosis International Bone DiseaseBone HealthDenosumab-induced HypocalcemiaMedicineOsteoporosis	2019	65
Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors Oded Icht, Naama Darzi, Shai Shimony, Journal of Thrombosis and Haemostasis	2021	61

Page 1